Small Pharma (CVE:DMT) Shares Up 7.1%

Small Pharma Inc. (CVE:DMTGet Rating)’s stock price shot up 7.1% during trading on Wednesday . The company traded as high as C$0.08 and last traded at C$0.08. 102,000 shares were traded during trading, a decline of 57% from the average session volume of 239,262 shares. The stock had previously closed at C$0.07.

Small Pharma Price Performance

The firm has a market capitalization of C$28.94 million, a PE ratio of -1.13 and a beta of 1.97. The company has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.10.

About Small Pharma

(Get Rating)

Small Pharma Inc, a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder.

See Also

Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with's FREE daily email newsletter.